Immunotherapy of genital warts with inosine pranobex (Imunovir): preliminary study.

AUTOR(ES)

Mohanty, K C

RESUMO

One hundred and sixty five heterosexual men and women with genital warts were treated with inosine pranobex (Imunovir) or conventional treatment, or both. Inosine pranobex was found to be more effective in lesions of longer duration, whereas conventional treatment was more effective in genital warts of a shorter duration. Supplementation of conventional treatment with inosine pranobex increased the success rate from 41% to 94%. Immunological studies in 134 patients with genital warts showed an increased number of B cells in 21% of peripheral blood samples. Absence of major defects among circulating lymphocytes suggested that patients with genital warts may have a local immune reaction.

Documentos Relacionados

• Immunotherapy of genital warts with inosine pranobex and conventional treatment: double blind placebo controlled study.
• Suppression of frequently recurring genital herpes: acyclovir v inosine pranobex.
• Effect of injections of small doses of human fibroblast interferon into genital warts. A pilot study.
• Podophyllin 10% and 25% in the treatment of ano-genital warts. A comparative double-blind study.
• Delayed presentation of patients with genital warts.